https://doi.org/10.4081/reumatismo.2021.1400

Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study)

Vol. 73 No. 3 (2021)
Published: November 22 2021
Rheumatoid arthritis, treatment adherence, disability, emotional intelligence, psychoeducation.
Abstract Views: 2443
PDF: 630
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

E. Cárdenas-Cloud
Master’s degree in Health Psychology, Department of Basic Psychology, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
A.J.L. Brambila-Tapia
aniel.brambila@academicos.udg.mx
https://orcid.org/0000-0002-6455-3662
Department of Basic Psychology, Centro Universitario de Ciencias de la Salud (CUCS), University of Guadalajara, Guadalajara, Jalisco, Mexico.
R.M. Meda-Lara
https://orcid.org/0000-0001-8967-7138
Department of Basic Psychology, Centro Universitario de Ciencias de la Salud (CUCS), University of Guadalajara, Guadalajara, Jalisco, Mexico.
F.d.J. Pérez-Vázquez
https://orcid.org/0000-0003-0697-9371
University of Guadalajara, University Center of Health Sciences, Department of Philosophical, Methodological and Instrumental Disciplines, Guadalajara, Jalisco, Mexico; University of Guadalajara, University Center for Health Sciences, Institute for Research in Rheumatology and the Musculoskeletal System, Department of Molecular Biology and Genomics Guadalajara, Jalisco, Mexico.
E. Chavarría-Ávila
https://orcid.org/0000-0001-7588-3870
University of Guadalajara, University Center for Health Sciences, Institute for Research in Rheumatology and the Musculoskeletal System, Department of Molecular Biology and Genomics Guadalajara, Jalisco, Mexico.
F.J. Romero-Abundis
University of Guadalajara, University Center for Health Sciences, Institute for Research in Rheumatology and the Musculoskeletal System, Department of Molecular Biology and Genomics Guadalajara, Jalisco, Mexico.
M. Vázquez-del-Mercado
https://orcid.org/0000-0002-3823-4676
University of Guadalajara, University Center for Health Sciences, Institute for Research in Rheumatology and the Musculoskeletal System, Department of Molecular Biology and Genomics Guadalajara, Jalisco, Mexico; Rheumatology Service, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jalisco, Mexico.

Our objective was to perform two studies: a cross-sectional study in order to identify the main psychological variables associated to treatment adherence in rheumatoid arthritis and an intervention based on psychoeducation to assess its impact on the variables identified in the first study. We measured treatment adherence, self-efficacy, beliefs about medication, emotional intelligence and disability along with personal and disease variables in the cross-sectional study and the same variables were measured in the intervention before and after the program and 3 months later in 2 groups (an experimental group and an active control group). In the cross-sectional study (N=33) we found that the variables most associated with treatment adherence were emotional clarity (r=0.352, p<0.05) and emotional repair (r=0.363, p<0.05). In the intervention, we divided the patients into 2 groups: the control group (N=7) and the intervention group (N=10). At the end of the study and at follow-up, we found a significant increase in adherence and self-efficacy in the intervention group, when compared with the control group. Emotional clarity was increased only in the post-test, and at follow up a decrease in beliefs of concern about medication was found. Psychoeducational programs based on information about the disease and its treatment together with emotional management are effective in increasing treatment adherence in the long term.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Wabe N, Lee A, Wechalekar M, et al. Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients. Int J Clin Pract. 2019; 73: e13375 DOI: https://doi.org/10.1111/ijcp.13375
van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Exp Rev Clin Immunol. 2012; 8: 337-51. DOI: https://doi.org/10.1586/eci.12.23
Lavielle M, Puyraimond-Zemmour D, Romand X, et al. Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review. RMD Open. 2018; 4: e000684. DOI: https://doi.org/10.1136/rmdopen-2018-000684
Evers A WM, Kraaimaat FW, van Riel PLCM, de Jong AJL. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain. 2002; 100: 141-53. DOI: https://doi.org/10.1016/S0304-3959(02)00274-9
Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2001; 60: 869-75.
Ravindran V, Jadhav R. The effect of rheumatoid arthritis disease education on adherence to medications and followup in Kerala, India. J Rheumatol. 2013; 40: 1460-1. DOI: https://doi.org/10.3899/jrheum.130350
Mary A, Boursier A, Desailly Henry I, et al. Mobile phone text messages improve treatment adherence in patients taking methotrexate for rheumatoid arthritis: a randomized pilot study. Arthrit Care Res. 2019; 71: 1344-52. DOI: https://doi.org/10.1002/acr.23750
Fernandez-Berrocal P, Extremera N, Ramos N. Validity and reliability of the Spanish modified version of the trait meta-mood scale. Psychol. Rep. 2004; 94: 751-55. DOI: https://doi.org/10.2466/pr0.94.3.751-755
Sanjuán-Suárez P, Pérez-García AM, Bermúdez-Moreno J. Escala de autoeficacia general: datos psicométricos de la adaptación para población española. Psicothema. 2000; 12: 509-13.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthrit Rheum. 1988; 31: 315-24. DOI: https://doi.org/10.1002/art.1780310302
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthrit Rheum. 2010; 62: 2569-81. DOI: https://doi.org/10.1002/art.27584
Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol. 2005; 23: S14-18.
Durán J, Domínguez A, Espinoza M. Evaluation of the Health Assessment Questionnaire Disability Index in Chilean patients with rheumatoid arthritis. Rev Med Chil. 2019; 147: 612-17. DOI: https://doi.org/10.4067/S0034-98872019000500612
Beléndez-Vázquez M, Herández-Mijárez A, Horne R, Weinman J. Evaluación de las creencias sobre el tratamiento: validez y fiabilidad de la version española del Beliefs about Medicines questionnaire. Int J Clin Health Psychol. 2007; 7: 767-779.
Ortega Suárez FJ, Sánchez Plumed J, Pérez Valentín MA, et al. Grupo de Estudio Vatren. Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus. Nefrologia 2011; 31: 690-6.
Knobel H, Alonso J, Casado JL, et al. GEEMA Study Group. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study 2002. AIDS. 2003; 16: 605-13. DOI: https://doi.org/10.1097/00002030-200203080-00012
Prevoo MLL, Van’T Hof MA, Kuper, HH, et al. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthrit Rheum. 1995; 38: 44-8. DOI: https://doi.org/10.1002/art.1780380107
Treharne G, Lyons A, Kitas G. Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Health Med. 2004; 9: 337-49. DOI: https://doi.org/10.1080/13548500410001721909
De Klerk E. Measurement of patient compliance on drug therapy an overview. In Vingerhoets A (Ed.), Advances in behavioral medicine assessment. London: Harwood academic publishers; 2001.
Brus H, van de Laar M, Taal E, et al. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns. 1999; 36: 57-64. DOI: https://doi.org/10.1016/S0738-3991(98)00087-1
McEwen BS, Gray JD, Nasca C. 60 Years of Neuroendocrinology: Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation. J Endocrinol. 2015; 226: T67-T83. DOI: https://doi.org/10.1530/JOE-15-0121
Irwin MR, Cole SW. Reciprocal regulation of the neural and innate immune systems. Nature Rev Immunol. 2011; 11: 625-32. DOI: https://doi.org/10.1038/nri3042
Pariante CM. Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. Eur Neuropsychopharmacol. 2017; 27: 554-59. DOI: https://doi.org/10.1016/j.euroneuro.2017.04.001

How to Cite



Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study). (2021). Reumatismo, 73(3). https://doi.org/10.4081/reumatismo.2021.1400

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.


Similar Articles

1-10 of 616

You may also start an advanced similarity search for this article.